Skip to content

Cytek Biosciences, Inc.

CTKB

CIK 0001831915 · Laboratory Analytical Instruments · Nasdaq

← back to feed
Revenue (TTM)
$183.49M
+0.5% YoY Q1 Apr 2026
Net Income (TTM)
−$40.83M
−1,005.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.01
−550.0% YoY Q1 Apr 2026
Gross Margin
50.6%
Q1 Apr 2026
Operating Margin
-29.0%
Q1 Apr 2026
Net Margin
-22.2%
Q1 Apr 2026
Free Cash Flow (TTM)
−$135K
Q1 Apr 2026
Cash
$65.67M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
129.14M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings